The product.
A simple blood test to detect folate receptor autoantibodies (FRAA)
-
0.02 ml vs 2-4 ml by only available other competitor
-
100x vs standard immunoassay technology in the market
-
Rapid results vs weeks of lab testing in the United States
-
Diagnosis at earlier stage in life allows for earlier treatment
-
Our licensed Multiplexing Technology allows to test several biomarkers at once
Nevarra’s FRAA blood test
The commercial application.
The first certified blood test to detect folate receptor autoantibodies and diagnose Cerebral Folate Deficiency (CFD)
Exclusively licensed operating system
The operating system.
FluoBolt Technology by Fianostics, patented and exclusively licensed to Nevarra Labs for ASD/CFD applications